سعر بروستافازين 20مكجم امبولات 2022

Alprostadil (prostaglandin E1) 20 microgram ampoules of powder for infusion; in Germany this brand is used for chronic peripheral arterial occlusive disease stage III-IV when revascularisation is not possible.

• Chronic peripheral arterial occlusive disease stage III and IV when lumen-widening therapy is not possible or has failed (IV use not recommended in stage IV)Population: Adultsmedikamio (copy of German Gebrauchsinformation)

• Very common: pain at the administration site; erythema and oedema of the infused limb after intra-arterial use. Common: headache, sensory disturbance in the affected limb, flushing, oedema, redness of the infused vein.International label, same formulation · medikamio (copy of German Gebrauchsinformation)
• Uncommon: confusion, hypotension, tachycardia, angina, gastrointestinal upset (diarrhoea, nausea, vomiting).International label, same formulation · medikamio (copy of German Gebrauchsinformation)

• Hypersensitivity to alprostadil or excipients; significant heart failure, uncontrolled arrhythmia or coronary disease, significant valve disease, myocardial infarction within 6 months.International label, same formulation · medikamio (copy of German Gebrauchsinformation)
• Pulmonary oedema or infiltration, severe COPD or veno-occlusive lung disease; liver disease or raised transaminases/GGT; severe renal impairment (oliguria, GFR <= 29).International label, same formulation · medikamio (copy of German Gebrauchsinformation)
• Bleeding tendency or active/potential bleeding sites (e.g. erosive gastritis, active peptic ulcer), cerebral haemorrhage, stroke within 6 months, polytrauma, severe hypotension.International label, same formulation · medikamio (copy of German Gebrauchsinformation)

• Monitor closely at every dose; patients with age-related tendency to heart failure or coronary disease need inpatient monitoring during treatment and one day after; check blood pressure, heart rate and fluid balance.International label, same formulation · medikamio (copy of German Gebrauchsinformation)
• Women of childbearing potential must use effective contraception during treatment.International label, same formulation · medikamio (copy of German Gebrauchsinformation)

• Must not be given to pregnant women; contraindicated in pregnancy.International label, same formulation · medikamio (copy of German Gebrauchsinformation)
• Contraindicated during breastfeeding.International label, same formulation · medikamio (copy of German Gebrauchsinformation)